期刊文献+

替米沙坦对早期糖尿病肾病患者C反应蛋白的影响 被引量:1

下载PDF
导出
摘要 目的探讨替米沙坦超对早期糖尿病肾病患者C反应蛋白水平的影响。方法选择2型糖尿病住院患者74例作为观察对象,微量白蛋白尿组(n=74),同时常规治疗组70例作为对照组。随后分别用胶乳增强免疫比浊法测定CRP、血肌酐(Scr)、尿白蛋白(UAlb),比较各组间的差异。结果2型糖尿病肾病组CRP水平随尿白蛋白排泄量和血肌酐(Scr)水平的增加而升高,治疗组疗程结束后,治疗组血清CRP降低(P<0.01),对照组降低不明显(P>0.05),组间差异有统计学意义(P<0.01)。结论替米沙坦有降低C反应蛋白水平的作用,对早期糖尿病肾病有更好的肾脏保护作用。
作者 晋青
机构地区 黑龙江省医院
出处 《中国现代药物应用》 2009年第16期209-210,共2页 Chinese Journal of Modern Drug Application
  • 相关文献

参考文献6

  • 1吴恒莲,林宏初.2型糖尿病及非糖尿病大血管病变患者血清C-反应蛋白水平分析[J].广东医学,2004,25(3):271-272. 被引量:10
  • 2Yokota T, OritaniK,Takahashi I,et al. Adiponectin, a new mem-ber of the family of soluble defense collagens, negatively regulatesthe growth of myelomonocytic progenitors and the functions ofmacrophages. Blood ,2000,96 (5) : 1723-1732.
  • 3Lam KS, Xu A. Adiponectin: protection of the endothelium. Curr Diab Rep ,2005,5 (4) :254-259.
  • 4Joachim S, Anja K, Matthias M, et al. Aiponectin and protegtionagainst type 2 diabetes mellitus. Lancet, 2003, 361 (9358): 226 -228.
  • 5Yang WS, Jeng CY, Wu TJ, et al. Synthetic peroxisome prolifer - ator - activated receptor - γagonist, rosiglitazone increase plasma lev-els of adionectin in type 2 diabetic patients. Diabetes Care, 2002,25 (2) :376-380.
  • 6袁国跃,周丽斌,唐金凤,杨颖,顾卫琼,李凤英,洪洁,顾燕云,徐敏,杜鹏飞,李小英,宁光,陈名道.糖耐量受损和2型糖尿病患者血清C反应蛋白与胰岛素敏感指数、脂联素的关系[J].中华内分泌代谢杂志,2005,21(6):507-510. 被引量:50

二级参考文献26

  • 1王先令,陆菊明,潘长玉.不同糖耐量水平者血清C反应蛋白水平及阿卡波糖干预的影响[J].中华内分泌代谢杂志,2003,19(4):254-256. 被引量:43
  • 2吴伟华,张巾超,于江波,刘国良.2型糖尿病及合并大血管病变糖尿病患者C反应蛋白水平观察[J].中华内分泌代谢杂志,2003,19(4):257-259. 被引量:68
  • 3朱麒钱,尤巧英,李成江,李红,沈建国,斯徐伟,官莉莉,俞钟明,楼大均,金华伟.C反应蛋白与2型糖尿病大血管病变危险因素的相关性研究[J].中华内分泌代谢杂志,2005,21(4):320-321. 被引量:104
  • 4Schmidt MI, Duncan BB, Scharrct AR, et al. Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study. Lancet, 1999,353:1649.
  • 5Barzilay JI, Abraham L, Heckbert SR, et al. The relation of markers of inflammation to the development of glucose disonters in the elderly: the cardiovascular health study. Diabetes, 2001,50:2384.
  • 6Pradhan AD, Manson JE, Rifai N, et al. C - reactive protein, interteukin 6, and risk of developing type 2 diabetes mellitus. JAMA, 2001.286: 327.
  • 7Haidari M, Javadi E, Sadeghi B, et al. Evaluation of C - reactive protein, a sensitive marker of inflammation, as a risk factor for stable coronary artery disease. Clin Biochem, 2001,33 : 309.
  • 8Torzewski J, Torzewski M, Bowyer DE, et al. C-reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries. Arterioscler Thromb Vase Biol, 1998,18 : 1386-1392.
  • 9Thorand B, Lowel H, Schneider A, et al. C-reactive protein as a predictor for incident diabetes mellitus among middle-aged men: results from the MONICA Augsburg cohort study, 1984 1998. Arch Intern Med, 2003,163:93-99.
  • 10Aronson D, Bartha P, Zinder O, et al. Association between fasting glucose and C-reactive protein in middle-aged subjects. Diabet Med, 2004,21:39-44.

共引文献56

同被引文献7

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部